Dr. Sanjay Gupta Spearheads American Pain Association’s Movement for Insurance Companies to Cover Cannabidiol (CBD) (CORRECTION)

BALA CYNWYD, Pa., Oct. 16, 2018  — Dr. Sanjay Gupta, President of the American Pain Association (APA)* and a pain management specialist based in Bala Cynwyd, Penn., is leading the push for insurance companies to cover cannabidiol (CBD) products for the treatment of pain and Opioid Use Disorder. Simply put,Read …

Read moreDr. Sanjay Gupta Spearheads American Pain Association’s Movement for Insurance Companies to Cover Cannabidiol (CBD) (CORRECTION)

Dr. Derrick DeSilva: Endocannabinoid System Clinical Uses, Dosage of Full-Spectrum Hemp Part 3 & 4

As part of our ongoing series on full-spectrum hemp, Dr. DeSilva and Today’s Practitioner’s Rob Lutz discusses the endocannabinoid system, hemp’s role as an adaptogen, what is the dosage for full-spectrum hemp?, along with many other pearls of wisdom. Click here for Part 1 & 2, Clinical Fundamentals of Full-SpectrumRead …

Read moreDr. Derrick DeSilva: Endocannabinoid System Clinical Uses, Dosage of Full-Spectrum Hemp Part 3 & 4

Clinical Fundamentals of Full-Spectrum Hemp with Dr. Derrick DeSilva, Part 1 & 2

Full-spectrum hemp is gaining a remarkable reputation among clinicians as a fundamental and safe botanical for a variety of clinical purposes. In these short videos, Derrick DeSilva, MD and Rob Lutz, founder of Today’s Practitioner, reviews the safety, side effects and clinical uses of full-spectrum hemp (cannabidiol). What you willRead …

Read moreClinical Fundamentals of Full-Spectrum Hemp with Dr. Derrick DeSilva, Part 1 & 2

Medical Cannabis Podcast with Chris Meletis, ND on Immunomodulatory & Anti-inflammatory Properties

In this podcast Micheal Ruscio, DC interviews Chris Meletis, ND on how to safely and effectively utilize cannabidiol (CBD) and medical cannabis in your practice. Most recently Dr. Meletis was featured in the Townsend Letter on a new medical certification program for practitioners prescribing CBD and other active constituents ofRead …

Read moreMedical Cannabis Podcast with Chris Meletis, ND on Immunomodulatory & Anti-inflammatory Properties

Early Lab Study: Hemp Shows Therapeutic Potential for Reducing Ovarian Cancer Risk

CBD, full-spectrum hemp

Could non-psychoactive hemp be a viable use to reduce ovarian cancer risk? As we learn more about the bioactives in hemp, the possibility becomes ever real. At the 2018 annual Experimental Biology meeting in San Diego, graduate students, Sara Biela and Chase Turner, presented the first study to examine hemp andRead …

Read moreEarly Lab Study: Hemp Shows Therapeutic Potential for Reducing Ovarian Cancer Risk

Beyond CBD: Exploring the Endocannabinoid System in Health and Disease, with Carl Germano PhD

Eureka! We’ve been on the search and finally found a refreshingly honest interview on the subject of the endocannabinoid system and the use of cannabidiol in clinical practice. Not surprisingly, it came from Carl Germano, PhD, RD, CNS, CDN. Germano has been in private practice in integrative and nutritional therapies

Read moreBeyond CBD: Exploring the Endocannabinoid System in Health and Disease, with Carl Germano PhD

Interview with Jeffrey Chen, MD and Raphael Mechoulan, PhD on Endocannabinoids

endocannabinoids

This video, Jeffrey Chen, MD, the Director of the UCLA Cannabis Research Initiative, is the best explanation of the mechanisms and action potential of endocannabinoids in the human body. This is followed by and interview with Raphael Mechoulan, PhD, professor of Medicinal Chemistry at the Hebrew University of Jerusalem. MechoulanRead …

Read moreInterview with Jeffrey Chen, MD and Raphael Mechoulan, PhD on Endocannabinoids

CBD Myth-Busting Study: High Doses of Cannabidiol Do Not Cause THC-Like Effects in Humans

CBD

Have you been hesitant to prescribe cannabidiol (CBD) because of concerns about gastric acids converting the CBD into psychoactive tetrahydrocannabinol (THC)? In 2016, a study by Merrick et al. suggested that when CBD is exposed to an acidic environment, it degrades to Δ9-tetrahydrocannabinol  and other psychoactive cannabinoids. The following isRead …

Read moreCBD Myth-Busting Study: High Doses of Cannabidiol Do Not Cause THC-Like Effects in Humans

Cannabidiol Offers Inflammatory Properties for Contact Dermatitis

This study is the first demonstration of the anti-inflammatory properties of Cannabidiol in an experimental model for allergic contact dermatitis (ACD). Published in the J. Pharmacology and Experimental Therapeutics, March 2018. Abstract / Phytocannabinoids modulate inflammatory responses by regulating the production of cytokines in several experimental models of inflammation. Cannabinoid type-2Read …

Read moreCannabidiol Offers Inflammatory Properties for Contact Dermatitis